How many email patterns does Nammi Therapeutics, Inc. use?

Nammi Therapeutics, Inc. uses 1 known email pattern.

What domain does Nammi Therapeutics, Inc. use for work emails?

Nammi Therapeutics, Inc. uses nammirx.com for work email addresses.

Most Common Email Formats at Nammi Therapeutics, Inc.

The most accurate and popular Nammi Therapeutics, Inc.'s email format is First.Last@nammirx.com (ex. John.Doe@nammirx.com). Nammi Therapeutics, Inc. also uses as email structures. Nammi Therapeutics, Inc. uses up to 1 different email patterns.

Nammi Therapeutics, Inc. Email Formats	Example	Percentage
First.Last@nammirx.com	John.Doe@nammirx.com	100%

Nammi Therapeutics, Inc. Email Formats

Example

Percentage

First.Last@nammirx.com

John.Doe@nammirx.com

100%

Frequently Asked Questions

What does Nammi Therapeutics, Inc. do?

The company's main headquarters is located in 10940 Wilshire Boulevard Suite 600 Los Angeles, California 90024 United Statesoperates in the Biotechnology Research industry, along with similar companies like RochesanofiJohnson & Johnson. You can visit nammirx.com. Explore Nammi Therapeutics, Inc.'s company overview page for more information.

What is Nammi Therapeutics, Inc.'s email address format?

Nammi Therapeutics, Inc.'s email format typically follows the pattern of First.Last@nammirx.com; this email format is used 100% of the time. Looking for more contact data? Unlock accurate emails and phone numbers from millions of profiles verified in real-time.

How many employees does Nammi Therapeutics, Inc. have currently?

Nammi Therapeutics, Inc. has approximately 9 employees as of June 2026. Key team members to contact include President And Ceo: D. S.Vice President, Technical Operations: S. A.. For more team information and contact data, explore Nammi Therapeutics, Inc.'s employee directory with LeadIQ.

Nammi Therapeutics, Inc. Email Format

Biotechnology ResearchCalifornia, United States2-10 Employees

Nammi Therapeutics, Inc. is a biotechnology company in the immuno-oncology field focusing on activating anti-tumor immunity within the tumor microenvironment while minimizing systemic immune activation. This approach is intended to improve safety and enable the combination of multiple immune modulators. Its lead candidate, QXL138AM, is a masked immunocytokine designed to deliver an interferon signal to the tumor antigen CD138; the company has also developed a nanoparticle delivery approach, Nammisome, with several candidates in development.
Nammi is based in Los Angeles, California, and operates with a small team serving the oncology research and development ecosystem through platform-based approaches. In August 2024, it disclosed plans to begin a first-in-human Phase 1 study for QXL138AM.

Most Common Email Formats at Nammi Therapeutics, Inc.

Frequently Asked Questions

What does Nammi Therapeutics, Inc. do?

What is Nammi Therapeutics, Inc.'s email address format?

How many employees does Nammi Therapeutics, Inc. have currently?

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

Nammi Therapeutics, Inc. Email Format

Verify Nammi Therapeutics, Inc. email addresses

Ready to create more pipeline?

Ready to create more pipeline?

Most Common Email Formats at Nammi Therapeutics, Inc.

Frequently Asked Questions

What does Nammi Therapeutics, Inc. do?

What is Nammi Therapeutics, Inc.'s email address format?

How many employees does Nammi Therapeutics, Inc. have currently?

Everything for prospecting,in one platform.

What you can expect from LeadIQ:

Nammi Therapeutics, Inc. Email Format

Verify Nammi Therapeutics, Inc. email addresses

Ready to create more pipeline?

Ready to create more pipeline?

Everything for prospecting,
in one platform.